The ultra-thin lens offering from Viltrox will soon be available in what the brand calls a "new flavor" for X-mount users.

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Left Coast Marketing & Design is proud to announce the much anticipated launch of BottleShots.ai, the first SaaS ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for ...

Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in the ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...

Nebius, the ultimate cloud for AI explorers, today announced the general availability of a number of leading open-source text-to-image AI models throu ...

Following that, we have some lifestyle images to show you. These come from Samsung itself, as the company has a tendency to release such images with every major launch. The Galaxy S series launch ...

This is Rumor Replay, a weekly column at 9to5Mac offering a quick rundown of the most recent Apple product rumors, with analysis and commentary. Today: Apple’s big 2025 product release plans ...

But, sometimes, no matter how many hydrating formulas you slather on your face or body, your skin can still feel parched (and that's coming from a beauty editor who tests products for a living).